PBSS-San Diego – Small Molecule Preclinical Development and IND Filing: Nuts, Bolts and Best Practices

We look forward to seeing you at the upcoming PBSS-San Diego Workshop!

Exhibitor

About the Meeting Topic:
Investigational new drug (IND) application is an important milestone that marks the entry of a molecule into clinical development. Knowing the objectives, expectations, and processes of assembling and filing an IND is the key to not only a successful filing but also a promising clinical development path forward. Often, there are cases where too many nice-to-have studies crowd in the package but critical studies/issues are not addressed, and this can lead to significant delays in clinical development. Additionally, the regulatory environment is changing as rapidly as the industry. Therefore, keeping up to date on the regulatory requirements and the industry’s best practices in different aspects including non-clinical safety, PK, CMC, and clinical plan is paramount.

Use the form below to schedule a meeting with the Alturas Team.

"*" indicates required fields

First Name*

Last Name*

Company*

Email*

Phone*

Interest*

Select Your InterestMethod Development/ValidationPre-clinical Sample AnalysisClinical Sample AnalysisPharmacokinetic/Toxicokinetic AnalysisSample StorageOther

Message

Consent*

I consent to receiving communications from Alturas Analytics. By clicking submit, I agree with the storage and handling of my data by Alturas Analytics.

Please review our Privacy Policy for more information. You can opt out at any time.

CAPTCHA